Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO - Concepedia

Concepedia

Publication | Open Access

Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO

DOI Full Paper Access

55

Citations

12

References

2016

Year

Elena K. Schneider‐Futschik, Felisa Reyes‐Ortega, John Wilson, Tom Kotsimbos, D. Keating, Jian Li, Tony Velkov

Journal of Chromatography B

Translational MedicineMedicineCystic Fibrosis PatientsLc–ms/ms MethodsImmunologyMajor MetabolitesClinical ChemistryPharmacology

References

	Year	Citations

Page 1